Fortress Biotech Inc (FBIO)
1.84
+0.01
(+0.55%)
USD |
NASDAQ |
May 31, 16:00
1.85
+0.01
(+0.54%)
After-Hours: 20:00
Fortress Biotech SG&A Expense (Quarterly): 17.94M for March 31, 2024
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 17.94M |
December 31, 2023 | 22.61M |
September 30, 2023 | 21.73M |
June 30, 2023 | 24.44M |
March 31, 2023 | 25.34M |
December 31, 2022 | 28.20M |
September 30, 2022 | 30.14M |
June 30, 2022 | 29.05M |
March 31, 2022 | 26.27M |
December 31, 2021 | 27.70M |
September 30, 2021 | 22.22M |
June 30, 2021 | 19.38M |
March 31, 2021 | 17.54M |
December 31, 2020 | 15.81M |
September 30, 2020 | 15.38M |
June 30, 2020 | 14.46M |
March 31, 2020 | 15.52M |
December 31, 2019 | 14.33M |
September 30, 2019 | 14.34M |
June 30, 2019 | 13.44M |
March 31, 2019 | 13.48M |
December 31, 2018 | 14.58M |
September 30, 2018 | 12.18M |
June 30, 2018 | 13.06M |
March 31, 2018 | 13.55M |
Date | Value |
---|---|
December 31, 2017 | -2.477M |
September 30, 2017 | 21.85M |
June 30, 2017 | 16.64M |
March 31, 2017 | 14.88M |
December 31, 2016 | 9.748M |
September 30, 2016 | 8.864M |
June 30, 2016 | 8.635M |
March 31, 2016 | 7.932M |
December 31, 2015 | 7.208M |
September 30, 2015 | 7.129M |
June 30, 2015 | 3.803M |
March 31, 2015 | 3.49M |
December 31, 2014 | 3.195M |
September 30, 2014 | 2.737M |
June 30, 2014 | 2.386M |
March 31, 2014 | 2.095M |
December 31, 2013 | 2.972M |
September 30, 2013 | 2.143M |
June 30, 2013 | 2.499M |
March 31, 2013 | 2.484M |
December 31, 2012 | 2.681M |
September 30, 2012 | 2.054M |
June 30, 2012 | 1.94M |
March 31, 2012 | 2.00M |
December 31, 2011 | 1.79M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
13.44M
Minimum
Jun 2019
30.14M
Maximum
Sep 2022
20.79M
Average
20.56M
Median
SG&A Expense (Quarterly) Benchmarks
Journey Medical Corp | 8.42M |
Avenue Therapeutics Inc | 1.316M |
Checkpoint Therapeutics Inc | 2.451M |
Mustang Bio Inc | 1.427M |
Viking Therapeutics Inc | 9.97M |